Home » Stocks » Global Cord Blood

Global Cord Blood Corporation (CO)

Stock Price: $3.48 USD -0.06 (-1.69%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 423.00M
Revenue (ttm) 174.49M
Net Income (ttm) 470.72M
Shares Out 121.55M
EPS (ttm) 0.29
PE Ratio 12.00
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $3.48
Previous Close $3.54
Change ($) -0.06
Change (%) -1.69%
Day's Open 3.57
Day's Range 3.48 - 3.57
Day's Volume 48,700
52-Week Range 2.54 - 5.79

More Stats

Market Cap 423.00M
Enterprise Value -358.41M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 121.55M
Float 34.73M
EPS (basic) n/a
EPS (diluted) 0.29
FCF / Share 0.71
Dividend n/a
Dividend Yield n/a
Earnings Yield 8.33%
FCF Yield 20.53%
Payout Ratio n/a
Shares Short 280,105
Short Ratio 3.27
Short % of Float 0.81%
Beta 0.50
PE Ratio 12.00
Forward PE n/a
P/FCF Ratio 4.87
PS Ratio 2.42
PB Ratio 0.71
Revenue 174.49M
Operating Income 79.86M
Net Income 470.72M
Free Cash Flow 86.85M
Net Cash 781.41M
Net Cash / Share 6.43
Gross Margin 84.52%
Operating Margin 45.77%
Profit Margin 38.50%
FCF Margin 49.77%
ROA 5.13%
ROE 13.28%
ROIC 58.80%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$15.00*
Low
15.0
Current: $3.48
High
15.0
Target: 15.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,221987937760663635573526380340
Revenue Growth23.79%5.34%23.26%14.63%4.39%10.87%8.88%38.28%12.06%-
Gross Profit1,032801755617518505467420294262
Operating Income559382280265191235234210135124
Net Income47129123712690.9710713211213291.70
Shares Outstanding12212180.0880.0880.0873.0073.0073.1475.4166.74
Earnings Per Share3.872.401.991.591.251.361.601.491.791.31
EPS Growth61.25%20.6%25.16%27.2%-8.09%-15%7.38%-16.76%36.64%-
Operating Cash Flow624792819638581595536579354177
Capital Expenditures-16.06-30.21-66.69-24.42-16.48-37.78-150-226-42.76-20.67
Free Cash Flow608762752613565557386353311156
Cash & Equivalents5,4734,9984,2513,5103,0082,4441,8831,494795611
Total Debt3.50--1,03196686883880245.0045.00
Net Cash / Debt5,4704,9984,2512,4792,0421,5761,045692750566
Assets7,2206,5515,8445,1834,6884,1123,6312,9861,8241,564
Liabilities3,3313,1282,7263,3402,9752,5682,1911,745589470
Book Value3,8823,4173,1131,8381,7091,5381,4351,2371,2031,071
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name Global Cord Blood Corporation
Country Hong Kong
Employees 1,260
CEO Ting Zheng

Stock Information

Ticker Symbol CO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NYSE: CO

Description

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).